Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04623476
Other study ID # 112/20
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 16, 2020
Est. completion date April 30, 2021

Study information

Verified date December 2020
Source University of Rome Tor Vergata
Contact Bruno Sensi, MD
Phone 3385352902
Email brunosensi@outlook.it
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Single centre prospective pilot study on surgery for Crohn's disease (CD). CD universally recurs after surgery and no technique so far has been proven to reduce recurrence. The investigators speculate that a different surgical technique, based on pathophysiology of the disease may prove successful in reducing rates of recurrence. Consecutive CD patients with a surgical indication for ileocolic disease will receive an extended procedure including a lymphadenectomy (Pathophysiologic excision for Crohn's disease). Primary outcome will be endoscopic recurrence rates at 6 and 12 months from surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 12
Est. completion date April 30, 2021
Est. primary completion date April 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All consecutive patients undergoing surgery for ileocaecal/ileocolic CD in the Minimally Invasive Unit at Policlinico Tor Vergata are eligible to be enrolled. - Informed consent Exclusion Criteria: - Crohn's Disease with a different localisation - Recurrent disease - Extensive jejunitis - <18 years of age - Cancer as primary indication for surgery - Followed by gastroenterologists outside our centre, due to loss of follow up - Ileostomy. If a patient undergoes ileostomy fashioning he will be excluded from the study and this will be reported

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Pathophysiological Excision for Crohn's disease
Pathophysiological excision for Crohn's (PEC) requires a medio-lateral approach and a high vascular tie, which enables excision of lymph nodes draining the disease bowel. This procedure should not alter length of bowel resection and no additional risks are foreseen. A latero-lateral anastomosis will be fashioned following current guidelines.

Locations

Country Name City State
Italy Policlinico Tor Vergata Roma RM

Sponsors (1)

Lead Sponsor Collaborator
University of Rome Tor Vergata

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of endoscopic CD recurrence Endoscopic Rutgeerts score >1 6 months
Primary Rate of endoscopic CD recurrence Endoscopic Rutgeerts score >1 12 months
Secondary Rate of overall postoperative complications Clavien Dindo I-V 30 days
Secondary Rate of major postoperative complications Clavien Dindo III-V 30 days
Secondary Overall and Disease specific Quality of life Inflammatory Bowel Disease Questionnaire (32 to 224 with higher scores representing better quality of life) 6 months
Secondary Overall and Disease specific Quality of life Inflammatory Bowel Disease-Control (Q 1-3 with higher scores representing better quality of life) 6 months
Secondary Overall and Disease specific Quality of life Cleveland Global Quality of Life score (0-1 with with higher scores representing better quality of life) 6 months
Secondary Overall and Disease specific Quality of life Inflammatory Bowel Disease Questionnaire (32 to 224 with higher scores representing better quality of life) 12 months
Secondary Overall and Disease specific Quality of life Inflammatory Bowel Disease-Control Q1-3 (0-18 with higher scores representing better quality of life) 12 months
Secondary Overall and Disease specific Quality of life Cleveland Global Quality of Life score (0-1 with higher scores representing better quality of life) 12 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04046913 - The ADDapt Diet in Reducing Crohn's Disease Inflammation N/A
Recruiting NCT05169593 - Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy Phase 4
Recruiting NCT06116604 - Early Bowel Resection for Terminal Ileal Crohn's Disease
Recruiting NCT05294107 - Intestinal Organoids N/A
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Recruiting NCT05627128 - A Culturally Tailored Dietary Intervention to Treat Crohn's Disease N/A
Withdrawn NCT04349449 - ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Completed NCT03058679 - Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease N/A
Completed NCT02871635 - BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity Phase 3
Recruiting NCT04539665 - Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease. N/A
Recruiting NCT04266600 - Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease N/A
Recruiting NCT03913572 - Treatment of Perianal Disease Using Adipose-derived Stem Cells
Completed NCT03606499 - Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
Completed NCT03668249 - A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
Terminated NCT04102111 - A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease Phase 2
Recruiting NCT04997733 - Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal Phase 3
Recruiting NCT05906576 - Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients Phase 4
Not yet recruiting NCT04502303 - 18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease Phase 2
Not yet recruiting NCT04398836 - Preoperative Nutrition for Crohn's Disease Patients Phase 3